Atomwise is a series b startup based in United States. 1 investor tracked.
Atomwise is a company founded in 2015 headquartered in the United States. Brouky records 3 investors associated with the company.
Atomwise uses artificial intelligence to accelerate drug discovery by predicting the binding of small molecules to proteins, aiding pharmaceutical research and development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.